Last quarter (Q2 2023), Aspen Pharmacare Holdings's total revenue was Rs―, a decrease of ― from the same quarter last year. In Q2, Aspen Pharmacare Holdings's net income was Rs―. See Aspen Pharmacare Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	-	Rs 38.61B	Rs 37.77B	Rs 33.66B	Rs 35.51B
Cost of Revenue	-	-	Rs 20.30B	Rs 19.98B	Rs 16.52B	Rs 16.97B
Gross Profit	-	-	Rs 18.31B	Rs 17.79B	Rs 17.14B	Rs 18.54B
Operating Expense	-	-	Rs 9.47B	Rs 9.66B	Rs 9.03B	Rs 9.65B
Operating Income	-	-	Rs 8.84B	Rs 8.13B	Rs 8.11B	Rs 8.89B
Net Non Operating Interest Income Expense	-	-	Rs -673.00M	Rs -1.14B	Rs -1.51B	Rs -2.08B
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	-	Rs 8.13B	Rs 5.99B	Rs 4.20B	Rs 2.35B
Tax Provision	-	-	Rs 1.65B	Rs 1.19B	Rs 818.00M	Rs 671.00M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	-	Rs 6.49B	Rs 4.81B	Rs 4.66B	Rs 6.46B
Basic EPS	-	-	Rs 14.32	Rs 10.53	Rs 10.22	Rs 14.16
Diluted EPS	-	-	Rs 14.32	Rs 10.53	Rs 10.22	Rs 14.16
Basic Average Shares	-	-	Rs 453.00M	Rs 456.50M	Rs 456.50M	Rs 456.40M
Diluted Average Shares	-	-	Rs 453.00M	Rs 456.50M	Rs 456.50M	Rs 456.40M
Dividend Per Share	-	-	Rs 2.62	Rs 0.00	Rs 0.00	Rs 3.15
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	Rs 16.28	Rs 13.10	Rs 14.65	Rs 13.45
Reported Normalized Diluted E P S	-	-	Rs 16.28	Rs 13.10	Rs 14.65	Rs 13.45
Rent Expense Supplemental	-	-	Rs 50.00M	Rs 84.00M	Rs 21.00M	Rs 123.00M
Total Expenses	-	-	Rs 29.77B	Rs 29.64B	Rs 25.55B	Rs 26.62B
Net Income From Continuing And Discontinued Operation	-	-	Rs 6.49B	Rs 4.81B	Rs 4.66B	Rs 6.46B
Normalized Income	-	-	Rs 6.56B	Rs 5.56B	Rs 4.91B	Rs 5.02B
Interest Expense	-	-	Rs 765.00M	Rs 1.21B	Rs 1.65B	Rs 2.23B
EBIT	-	-	Rs 8.90B	Rs 7.19B	Rs 5.85B	Rs 4.58B
EBITDA	-	Rs 9.67B	Rs 10.61B	Rs 8.85B	Rs 7.45B	Rs 5.85B

Currency in ZAR

Aspen Pharmacare Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing